NCT06513273View on ClinicalTrials.gov

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

RecruitingOBSERVATIONAL
Enrollment

397

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Acute Myeloid LeukemiaAML, AdultAcute Myeloid Leukemia, Adult
Trial Locations (2)

Unknown

RECRUITING

Ematologia Ente Ecclesiastico Casa Sollievo Della Sofferenza, San Giovanni Rotondo

RECRUITING

UOC Ematologia AOU di SASSARI, Sassari

All Listed Sponsors
lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER

NCT06513273 - Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial) | Biotech Hunter | Biotech Hunter